Category: Hill-Rom Holdings Inc.
Indiana-based Hill-Rom announces restructuring plans that will cut about 350 workers in hopes of saving $30 million per year as the company lowers its guidance for 2014.
Hill-Rom Holdings (NYSE:HRC) announced today that it will cut about 350 employees in efforts to save about $30 million annually as the device maker looks forward to a potentially tough year.
Ali Haghighi-Mood, the former president & CEO of Cambridge Heart, and chairman Roderick de Greef both resign for unnamed reasons.
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Hill-Rom Holdings releases its preliminary 2nd-quarter results and says CFO Mark Guinan is leaving the medical device company.
Hill-Rom's next generation airway clearing system lands a nod from the FDA
Hill-Rom Holdings (NYSE:HRC) landed 510(k) clearance from the FDA for its MetaNeb 4.0 airway clearing system, which combines airway oscillation and pressure to expand weak lungs and encourage normal mucus growth.
NxStage names Robert Funari its new chairman, following the resignation of Philippe Chambon after 15 years on the medical device company's board.
NxStage Medical (NSDQ:NXTM) named Robert Funari to replace Philippe Chambon as non-executive chairman after 15 years on the medical device company's board of directors.
Medical devices made a lot of headlines in 2012, and the word "layoffs" was in many of them.
The medical device industry had a lot of big stories during the last year, including tales of recalls, lawsuits and CEO swapping, but the single factor that drove more big headlines than any other was news of layoffs.
Some of the biggest companies in the industry announced significant cuts in 2012, amounting to about 7,000 reported layoffs, by some estimates.